Table 2.
Polymorphism | Pharmacokinetic parameters |
---|---|
ABCB1 C3435T (CC vs CT + TT) | CPT-11 Cmax (P = 0.047) |
ABCB1 haplotypes | |
″″″″(CC-GG-CC vs. CT-GT-CT vs TT-TT-TT) | SN-38G: Cmax (P = 0.055) |
″″″″ABCC2 C-24T (CC vs CT vs TT) | CPT-11 AUC(0,∞) (P = 0.055) |
″″″″ABCG2–19572–19569 CTCA del (CTCA vs Het + CTCA del) | REC (AUCSN-38/AUCCPT-11) (P = 0.019) |
″″″″ABCG2 G34A (GG vs GA + AA) | CPT-11 Cmax (P = 0.056) |